📢📢NEW research from @jthjournal.bsky.social! Two new papers were released on stroke risk and prediction in #atrialfibrillation. Whether you’re a clinician or researcher, you won’t want to miss these insights. Visit jthjournal.org to explore this new research. #stroke #afib #af

Who would have thought VTE management could be so much fun! Thank you @thecurbsiders.bsky.social 🫶🏼 #PharmSky #MedSky #CardioSky #SkyRx #HemeSky @anticoagforum.bsky.social

💥If you want to see practice changing highlights from #ISTH2025, you can check out the VLN Newsletter vln.thrombosis.org/c/clinical-r... or log in to the VLN ISTH 2025 Community Page lnkd.in/eyrrr4qZ to see ALL the posts and interact with the community. I look forward to seeing you there!

Vasculearn Network is hosting a Women's Health Support Group May 12th @ 7PM EST This is a safe & trusted space for patients to ask questions, receive educational resources & feel supported as they learn to VascuLive with their diagnosis 👉Register lnkd.in/esHHKW62

Did you know that NATF has rebranded? Check out the brand new Vasculearn Network: www.google.com/url?q=https:... Their dynamic site is full of great resources for patients & providers. I personally love their patient support groups and reading What’s Hot in Clots by @bbikdeli.bsky.social!

Outpatient management of CAT? Insightful review from @marccarriermd.bsky.social @drdebthrombo.bsky.social & colleagues publications.ersnet.org/content/erj/...

Excited to share an important new document from ACForum and FWGBD addressing the care of folks with the potential to menstruate (or enter menopause!) or become pregnant. Check it out! acforum.org/web/resource...

📢 Calling all Anticoagulation Specialists! Come join our comprehenisve management program. We care for patients on warfarin & DOACs with an emphasis on #Stewardship #Quality and #Equity Please reach out with any questions #jobs #hiring #pharmsky #skyrx #anticoagualtion jobs.bilh.org/job/cambridg...

The @medscape.com Heart of Cardiology 2025 conference started yesterday with several stellar presentations! Here are a few key take away points that I’ve been thinking about… www.heartofcardio.com/agenda

Ok, here is the big lesson learned: 💡 When setting up the transfer device the Balfaxar vial MUST be on a solid flat surface so you can push down with force - We observed team members just connecting the 2 vials, and this led to a loss in the seal & increased transfer times #pharmRx #SkyRx #PharmSky

💡In this study, < 25% of pts with a major bleed had documented discussions about LAAO & > 25% permanently 🚫 anticoag. Education & shared decision making is vital. These pt are still at risk for embolic events pubmed.ncbi.nlm.nih.gov/39644619/?ut... @gbarnesmd.bsky.social

I am a big fan of practicle papers! It is great to see how providers are handling these interactions and what the impact on patient outcomes #PharmRx #Skypharm #Hemesky #MedSky pubmed.ncbi.nlm.nih.gov/39643974/

Is anyone routinely checking DOAC levels and changing therapy as a result? Curious to see what others are doing in practice #SkyRx #PharmSky #MedSky pubmed.ncbi.nlm.nih.gov/38884944/

🚨 Help needed! We recently switched to Balfaxar and are having issues with reconstitution. Any tips or tricks? Nurses are reporting times > 10min which is not ideal. Thanks! #PharmRx #SkyRx #PharmSky #MedSky #HemeSky #CardioSky

👀 🚨 FDA denies full approval of Andexanet Can’t say I am surprised. It will be interesting to see what happens next #SkyRx #PharmSky #CardioSky #HemeSky firstwordpharma.com/story/5921956

💡Great for trainees! #AnticoagStewardship #CardioSky #MedSky #PharmSky #SkyRx @bbikdeli.bsky.social pubmed.ncbi.nlm.nih.gov/39557062/

🌟 Good read on how to apply the CHADSVaSc score in clinical practice @gbarnesmd.bsky.social & #GregoryLip #CardioSky #PharmSky #SkyRx #Afib #AnticoagStewardship pubmed.ncbi.nlm.nih.gov/39365222/

We *tried* to do a meta-analysis on menstrual bleeding in FXI inhibitor studies - not only is it not an outcome, but hardly any participants were capable of menstruation. We call for action to improve capture of HMB in anticoagulant trials in our latest @jthjournal.bsky.social pub. t.co/c26Y0umzOi

🚨 Great teaching article 💡Review of cancer therapies that ⬆️ risk of arrhythmias (Did you know Ibrutinib ⬆️ AF risk by 15 fold 🤯) 💡Rate control typically preferred 💡AC can be challenging in frail, pancytopenic, ⬆️🩸risk pts 💡👀 for DDIs 🌟Tailor therapy #CardioSky #SkyRx pubmed.ncbi.nlm.nih.gov/39551561/

Are your patients looking for a safe space to ask questions & receive accurate information about their blood clots? The Vasculearn Network, offers free monthly virtual support groups for patients with blood clots. Along with focused sessions for: -Long PE/CTEPH -Cancer -Women’s Health #HemeSky

What do we need to focus on de-prescribing on CVD? Dr. Schwartz gives a good state of the field. Polypharmacy 💊💊 + age = higher complications & 💊🚫 interactions. Huge need to systematically withdrawal low-value “inappropriate” medications #AHA24 #CardioSky

The CDC and WHO report a 20% increase in measles cases last year, driven by decreases in vaccination. This equated to 107,500 DEATHS, mostly in young children. This, in a PREVENTABLE disease. Can only imagine what that number will be if we get rid of all mandates.

🔊 Recording now available for the #ACForum "Ask the Experts" webinar! Watch here: bit.ly/3QLuunC Expert insights & Q&A session on: 🔹Thrombosis & Thrombophilia 🔹Valvular Disease & Anticoag 🔹Women's Health 🔹Inpatient Anticoag & Acute Care Management 🔹Outpatient Care #AnticoagStewardship

🌟Come Join Our Team🌟 🌟2 New Positions, remote/hyrbid🌟 We are looking for skilled Anticoag Pharmacists to grow our Stewardship program. This role will focus on CDTM based outpt mgmt of antithrombotic therapy #AnticoagStewardship #jobs #pharmacist jobs.bilh.org/job/burlingt...

💡Check out the BLEED study 🩸🩸 Woman on #Anticoagulation are at risk for ABNORMAL Uterine Bleeding It is important to understand the risk, proactively counsel, provide f/u & screening, and treat when indicated. Women don’t need to suffer 🫶🏼 #AnticoagStewardship pubmed.ncbi.nlm.nih.gov/39505000/

Excited to be a part of this amazing panel! It should be an excellent discussion! Hope to see you there 👀🫶🏼

Good Morning! Hoping to fine a new community to learn from and share information ✨ About me: Pharmacist x 18yrs Focus: Antithrombotic Management with an emphasis on #Stewardship Other Interests: 🧘🏻‍♀️, 🥾🏔️🚵‍♂️, 📖, TS🫶🏼 #MedSky #SkyRX #PharmSky